How to Choose a Safe Ketamine Clinic in 2026

The ketamine therapy landscape has expanded rapidly. What was once available only at a handful of academic medical centers is now offered by hundreds of clinics, telehealth programs, and independent practices across the United States. This growth has made treatment more accessible, but it has also introduced significant variability in quality and safety. A 2024 study published in ScienceDaily highlighted just how wide the gap can be between the best and worst ketamine providers.

For a comprehensive overview of what to consider when selecting a provider, see our guide to choosing a ketamine provider. This post provides a practical, updated checklist for 2026.

What the Research Found

The 2024 study surveyed ketamine clinics and programs to assess their safety practices, clinical protocols, and patient screening procedures. The findings were sobering:

• Screening variability: Some clinics performed thorough medical and psychiatric evaluations before prescribing ketamine, while others conducted minimal or cursory assessments.
• Monitoring differences: Vital sign monitoring during and after treatment ranged from comprehensive to essentially absent.
• Follow-up gaps: Many clinics provided ketamine sessions without structured follow-up, outcome tracking, or coordination with the patient's broader treatment team.
• Credential variation: The medical professionals overseeing ketamine treatment ranged from board-certified psychiatrists to practitioners with minimal mental health training.

The takeaway: patients cannot assume that all ketamine providers meet the same standards. Due diligence matters.

What to Look For

Medical Oversight

The single most important factor in choosing a ketamine provider is the quality of medical oversight. Look for:

• Board-certified physicians: Ideally psychiatrists or anesthesiologists with specific training in ketamine therapy. The prescribing clinician should have expertise in both the pharmacology of ketamine and the psychiatric conditions it treats.
• Individual assessment: Your provider should conduct a thorough initial evaluation that includes psychiatric history, medical history, current medications, substance use history, and a risk-benefit discussion specific to your situation.
• Ongoing monitoring: Treatment should include regular check-ins, mood assessments using validated instruments (like the PHQ-9 or GAD-7), and dose adjustments based on your response.

Safety Protocols

Ask specifically about safety practices:

• Vital sign monitoring: Blood pressure and heart rate should be checked before and during treatment, particularly for the first few sessions.
• Emergency protocols: The provider should have clear procedures for managing adverse reactions, including dissociative crises, cardiovascular changes, and allergic reactions.
• Contraindication screening: Responsible providers screen for conditions that may make ketamine unsafe, including uncontrolled hypertension, certain cardiac conditions, active psychosis, and pregnancy.
• Support person requirement: For at-home treatment, a responsible adult should be present during your session. Providers that do not require this are cutting a critical safety corner.

Outcome Tracking

Quality programs track and report their outcomes. This matters because:

• It demonstrates accountability and a commitment to evidence-based practice.
• It allows the provider to adjust your treatment based on objective data, not just subjective impressions.
• It gives you a realistic expectation of likely results.

Isha Health publishes its clinical outcomes transparently, including response rates, improvement metrics, and patient population data.

Integration with Broader Care

Ketamine therapy should not exist in isolation. The best providers:

• Coordinate with your existing therapist or psychiatrist
• Encourage concurrent psychotherapy
• Provide or facilitate access to therapeutic support during the neuroplasticity window
• Develop a comprehensive treatment plan that includes ketamine as one component of a broader strategy

Red Flags

Be cautious of providers who:

• Prescribe without a thorough evaluation: If you can get ketamine prescribed after a five-minute consultation, the provider is not taking safety seriously.
• Do not track outcomes: If a clinic cannot tell you their response and remission rates, they may not be monitoring whether their treatment is working.
• Offer ketamine for conditions without evidence: While ketamine has demonstrated efficacy for depression, anxiety, PTSD, and certain pain conditions, providers marketing it as a cure-all for any condition should raise skepticism.
• Do not discuss risks: Every medication has risks and side effects. A provider who minimizes or avoids discussing ketamine's risks is not practicing informed consent.
• Have no emergency protocols: Ask what happens if you have a bad reaction. If the answer is vague, look elsewhere.
• Discourage concurrent therapy: Providers who position ketamine as sufficient on its own, without recommending psychotherapy, are ignoring substantial evidence that combination treatment produces better outcomes.
• Use high-pressure sales tactics: Quality medical care does not require urgency-based selling. Be wary of limited-time offers, package deals with no clinical rationale, or pressure to commit before you are ready.

Questions to Ask

Before committing to any ketamine provider, ask these questions:

1. What are the credentials of the prescribing physician?
2. What does the initial evaluation include?
3. How do you monitor my response to treatment?
4. What are your safety protocols during sessions?
5. What outcome data can you share?
6. How do you coordinate with my existing treatment team?
7. What happens if I have an adverse reaction?
8. Do you recommend psychotherapy alongside treatment?
9. What is your approach to dosing and dose adjustments?
10. What does your program include beyond the ketamine itself?

At-Home vs. In-Clinic: Safety Considerations

Both models can be delivered safely, but each has specific considerations:

In-clinic advantages: Direct medical observation, immediate access to emergency equipment, controlled environment.

At-home advantages: Familiar and comfortable environment (which can improve the therapeutic experience), no transportation needed, ability to rest immediately after treatment, and often more affordable.

The key is that whichever model you choose, the provider maintains rigorous safety protocols appropriate to the setting. Isha Health's at-home program includes physician oversight, safety screening, support person requirements, and standardized monitoring, designed to bring clinical-grade safety into the home environment.

The Bottom Line

The rapid expansion of ketamine therapy is a net positive for patients who need it. But not all providers are equal, and the 2024 research confirms that safety standards vary widely. Take the time to evaluate your options, ask direct questions, and choose a provider that prioritizes your safety as much as your outcomes.

Considering ketamine therapy? Isha Health offers physician-led at-home treatment with an 88.8% improvement rate. Check appointment availability.